United States Injectable Anticoagulants Market Report 2017

November 2017 | 104 pages | ID: U8030705BF7EN
QYResearch

Abstracts

In this report, the United States Injectable Anticoagulants market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Injectable Anticoagulants in these regions, from 2012 to 2022 (forecast).

United States Injectable Anticoagulants market competition by top manufacturers/players, with Injectable Anticoagulants sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Sanofi
• Genentech (Roche)
• Boehringer Ingelheim
• Pfizer
• The Medicines Company
• Aspen
• Otsuka

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Low-molecular-weight Heparin (LMWH)
• Direct Thrombin Inhibitor (DTI)
• Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• VTE
• ACS/MI
• AF
• Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Injectable Anticoagulants Market Report 2017

1 INJECTABLE ANTICOAGULANTS OVERVIEW

1.1 Product Overview and Scope of Injectable Anticoagulants
1.2 Classification of Injectable Anticoagulants by Product Category
  1.2.1 United States Injectable Anticoagulants Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Injectable Anticoagulants Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Low-molecular-weight Heparin (LMWH)
  1.2.4 Direct Thrombin Inhibitor (DTI)
  1.2.5 Other
1.3 United States Injectable Anticoagulants Market by Application/End Users
  1.3.1 United States Injectable Anticoagulants Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 VTE
  1.3.3 ACS/MI
  1.3.4 AF
  1.3.5 Other
1.4 United States Injectable Anticoagulants Market by Region
  1.4.1 United States Injectable Anticoagulants Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Injectable Anticoagulants Status and Prospect (2012-2022)
  1.4.3 Southwest Injectable Anticoagulants Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Injectable Anticoagulants Status and Prospect (2012-2022)
  1.4.5 New England Injectable Anticoagulants Status and Prospect (2012-2022)
  1.4.6 The South Injectable Anticoagulants Status and Prospect (2012-2022)
  1.4.7 The Midwest Injectable Anticoagulants Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Injectable Anticoagulants (2012-2022)
  1.5.1 United States Injectable Anticoagulants Sales and Growth Rate (2012-2022)
  1.5.2 United States Injectable Anticoagulants Revenue and Growth Rate (2012-2022)

2 UNITED STATES INJECTABLE ANTICOAGULANTS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Injectable Anticoagulants Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Injectable Anticoagulants Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Injectable Anticoagulants Average Price by Players/Suppliers (2012-2017)
2.4 United States Injectable Anticoagulants Market Competitive Situation and Trends
  2.4.1 United States Injectable Anticoagulants Market Concentration Rate
  2.4.2 United States Injectable Anticoagulants Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Injectable Anticoagulants Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES INJECTABLE ANTICOAGULANTS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Injectable Anticoagulants Sales and Market Share by Region (2012-2017)
3.2 United States Injectable Anticoagulants Revenue and Market Share by Region (2012-2017)
3.3 United States Injectable Anticoagulants Price by Region (2012-2017)

4 UNITED STATES INJECTABLE ANTICOAGULANTS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Injectable Anticoagulants Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Injectable Anticoagulants Revenue and Market Share by Type (2012-2017)
4.3 United States Injectable Anticoagulants Price by Type (2012-2017)
4.4 United States Injectable Anticoagulants Sales Growth Rate by Type (2012-2017)

5 UNITED STATES INJECTABLE ANTICOAGULANTS SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Injectable Anticoagulants Sales and Market Share by Application (2012-2017)
5.2 United States Injectable Anticoagulants Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES INJECTABLE ANTICOAGULANTS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Sanofi
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Injectable Anticoagulants Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Sanofi Injectable Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Genentech (Roche)
  6.2.2 Injectable Anticoagulants Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Genentech (Roche) Injectable Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Boehringer Ingelheim
  6.3.2 Injectable Anticoagulants Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Boehringer Ingelheim Injectable Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Pfizer
  6.4.2 Injectable Anticoagulants Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Pfizer Injectable Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 The Medicines Company
  6.5.2 Injectable Anticoagulants Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 The Medicines Company Injectable Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Aspen
  6.6.2 Injectable Anticoagulants Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Aspen Injectable Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Otsuka
  6.7.2 Injectable Anticoagulants Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Otsuka Injectable Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview

7 INJECTABLE ANTICOAGULANTS MANUFACTURING COST ANALYSIS

7.1 Injectable Anticoagulants Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Injectable Anticoagulants

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Injectable Anticoagulants Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Injectable Anticoagulants Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES INJECTABLE ANTICOAGULANTS MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Injectable Anticoagulants Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Injectable Anticoagulants Sales Volume Forecast by Type (2017-2022)
11.3 United States Injectable Anticoagulants Sales Volume Forecast by Application (2017-2022)
11.4 United States Injectable Anticoagulants Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Injectable Anticoagulants
Figure United States Injectable Anticoagulants Market Size (K MT) by Type (2012-2022)
Figure United States Injectable Anticoagulants Sales Volume Market Share by Type (Product Category) in 2016
Figure Low-molecular-weight Heparin (LMWH) Product Picture
Figure Direct Thrombin Inhibitor (DTI) Product Picture
Figure Other Product Picture
Figure United States Injectable Anticoagulants Market Size (K MT) by Application (2012-2022)
Figure United States Sales Market Share of Injectable Anticoagulants by Application in 2016
Figure VTE Examples
Table Key Downstream Customer in VTE
Figure ACS/MI Examples
Table Key Downstream Customer in ACS/MI
Figure AF Examples
Table Key Downstream Customer in AF
Figure Other Examples
Table Key Downstream Customer in Other
Figure United States Injectable Anticoagulants Market Size (Million USD) by Region (2012-2022)
Figure The West Injectable Anticoagulants Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Injectable Anticoagulants Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Injectable Anticoagulants Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Injectable Anticoagulants Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Injectable Anticoagulants Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Injectable Anticoagulants Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Injectable Anticoagulants Sales (K MT) and Growth Rate (2012-2022)
Figure United States Injectable Anticoagulants Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Injectable Anticoagulants Market Major Players Product Sales Volume (K MT) (2012-2017)
Table United States Injectable Anticoagulants Sales (K MT) of Key Players/Suppliers (2012-2017)
Table United States Injectable Anticoagulants Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Injectable Anticoagulants Sales Share by Players/Suppliers
Figure 2017 United States Injectable Anticoagulants Sales Share by Players/Suppliers
Figure United States Injectable Anticoagulants Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Injectable Anticoagulants Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Injectable Anticoagulants Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Injectable Anticoagulants Revenue Share by Players/Suppliers
Figure 2017 United States Injectable Anticoagulants Revenue Share by Players/Suppliers
Table United States Market Injectable Anticoagulants Average Price (USD/MT) of Key Players/Suppliers (2012-2017)
Figure United States Market Injectable Anticoagulants Average Price (USD/MT) of Key Players/Suppliers in 2016
Figure United States Injectable Anticoagulants Market Share of Top 3 Players/Suppliers
Figure United States Injectable Anticoagulants Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Injectable Anticoagulants Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Injectable Anticoagulants Product Category
Table United States Injectable Anticoagulants Sales (K MT) by Region (2012-2017)
Table United States Injectable Anticoagulants Sales Share by Region (2012-2017)
Figure United States Injectable Anticoagulants Sales Share by Region (2012-2017)
Figure United States Injectable Anticoagulants Sales Market Share by Region in 2016
Table United States Injectable Anticoagulants Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Injectable Anticoagulants Revenue Share by Region (2012-2017)
Figure United States Injectable Anticoagulants Revenue Market Share by Region (2012-2017)
Figure United States Injectable Anticoagulants Revenue Market Share by Region in 2016
Table United States Injectable Anticoagulants Price (USD/MT) by Region (2012-2017)
Table United States Injectable Anticoagulants Sales (K MT) by Type (2012-2017)
Table United States Injectable Anticoagulants Sales Share by Type (2012-2017)
Figure United States Injectable Anticoagulants Sales Share by Type (2012-2017)
Figure United States Injectable Anticoagulants Sales Market Share by Type in 2016
Table United States Injectable Anticoagulants Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Injectable Anticoagulants Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Injectable Anticoagulants by Type (2012-2017)
Figure Revenue Market Share of Injectable Anticoagulants by Type in 2016
Table United States Injectable Anticoagulants Price (USD/MT) by Types (2012-2017)
Figure United States Injectable Anticoagulants Sales Growth Rate by Type (2012-2017)
Table United States Injectable Anticoagulants Sales (K MT) by Application (2012-2017)
Table United States Injectable Anticoagulants Sales Market Share by Application (2012-2017)
Figure United States Injectable Anticoagulants Sales Market Share by Application (2012-2017)
Figure United States Injectable Anticoagulants Sales Market Share by Application in 2016
Table United States Injectable Anticoagulants Sales Growth Rate by Application (2012-2017)
Figure United States Injectable Anticoagulants Sales Growth Rate by Application (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Injectable Anticoagulants Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Sanofi Injectable Anticoagulants Sales Growth Rate (2012-2017)
Figure Sanofi Injectable Anticoagulants Sales Market Share in United States (2012-2017)
Figure Sanofi Injectable Anticoagulants Revenue Market Share in United States (2012-2017)
Table Genentech (Roche) Basic Information List
Table Genentech (Roche) Injectable Anticoagulants Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Genentech (Roche) Injectable Anticoagulants Sales Growth Rate (2012-2017)
Figure Genentech (Roche) Injectable Anticoagulants Sales Market Share in United States (2012-2017)
Figure Genentech (Roche) Injectable Anticoagulants Revenue Market Share in United States (2012-2017)
Table Boehringer Ingelheim Basic Information List
Table Boehringer Ingelheim Injectable Anticoagulants Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Boehringer Ingelheim Injectable Anticoagulants Sales Growth Rate (2012-2017)
Figure Boehringer Ingelheim Injectable Anticoagulants Sales Market Share in United States (2012-2017)
Figure Boehringer Ingelheim Injectable Anticoagulants Revenue Market Share in United States (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Injectable Anticoagulants Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Pfizer Injectable Anticoagulants Sales Growth Rate (2012-2017)
Figure Pfizer Injectable Anticoagulants Sales Market Share in United States (2012-2017)
Figure Pfizer Injectable Anticoagulants Revenue Market Share in United States (2012-2017)
Table The Medicines Company Basic Information List
Table The Medicines Company Injectable Anticoagulants Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure The Medicines Company Injectable Anticoagulants Sales Growth Rate (2012-2017)
Figure The Medicines Company Injectable Anticoagulants Sales Market Share in United States (2012-2017)
Figure The Medicines Company Injectable Anticoagulants Revenue Market Share in United States (2012-2017)
Table Aspen Basic Information List
Table Aspen Injectable Anticoagulants Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Aspen Injectable Anticoagulants Sales Growth Rate (2012-2017)
Figure Aspen Injectable Anticoagulants Sales Market Share in United States (2012-2017)
Figure Aspen Injectable Anticoagulants Revenue Market Share in United States (2012-2017)
Table Otsuka Basic Information List
Table Otsuka Injectable Anticoagulants Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Otsuka Injectable Anticoagulants Sales Growth Rate (2012-2017)
Figure Otsuka Injectable Anticoagulants Sales Market Share in United States (2012-2017)
Figure Otsuka Injectable Anticoagulants Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Injectable Anticoagulants
Figure Manufacturing Process Analysis of Injectable Anticoagulants
Figure Injectable Anticoagulants Industrial Chain Analysis
Table Raw Materials Sources of Injectable Anticoagulants Major Players/Suppliers in 2016
Table Major Buyers of Injectable Anticoagulants
Table Distributors/Traders List
Figure United States Injectable Anticoagulants Sales Volume (K MT) and Growth Rate Forecast (2017-2022)
Figure United States Injectable Anticoagulants Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Injectable Anticoagulants Price (USD/MT) Trend Forecast (2017-2022)
Table United States Injectable Anticoagulants Sales Volume (K MT) Forecast by Type (2017-2022)
Figure United States Injectable Anticoagulants Sales Volume (K MT) Forecast by Type (2017-2022)
Figure United States Injectable Anticoagulants Sales Volume (K MT) Forecast by Type in 2022
Table United States Injectable Anticoagulants Sales Volume (K MT) Forecast by Application (2017-2022)
Figure United States Injectable Anticoagulants Sales Volume (K MT) Forecast by Application (2017-2022)
Figure United States Injectable Anticoagulants Sales Volume (K MT) Forecast by Application in 2022
Table United States Injectable Anticoagulants Sales Volume (K MT) Forecast by Region (2017-2022)
Table United States Injectable Anticoagulants Sales Volume Share Forecast by Region (2017-2022)
Figure United States Injectable Anticoagulants Sales Volume Share Forecast by Region (2017-2022)
Figure United States Injectable Anticoagulants Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources